LSE - Delayed Quote GBp

Haleon plc (HLN.L)

386.40

+5.90

+(1.55%)

At close: 4:39:22 PM GMT+1

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

Pfizer sells 7.3% remaining stake in Haleon. FDA approves the expanded use of JNJ and NVS drugs.

Zacks last month

AZN

HLN

PFE
Sensodyne-maker axes diversity targets from bonuses

Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on DEI.

The Telegraph last month

HLN
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.

Zacks last month

PFE

HLN
Pfizer sells 7.3% stake in Haleon for $3.3bn

The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.

Pharmaceutical Technology last month

PFE

HLN
Top Midday Stories: EC Notifies Alphabet of DMA Noncompliance, Adopts Requirements for Apple; Boeing Expects Less Q1 Cash Outflow

All three major US stock indexes were up in late-morning trading as investors await the Federal Rese

PREMIUM
MT Newswires last month

BA

HLN

PFE
Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant

Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder

GuruFocus.com last month

PFE

HLN

GSK
Pfizer offloads final shares in Sensodyne maker Haleon

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.

PA Media: Money last month

PFE

HLN
Pfizer sells entire Haleon stake for $3.24 billion

Under the deal, Sensodyne maker Haleon has agreed to buy back 44 million shares from Pfizer, currently its largest shareholder, with 618 million shares being sold to institutional investors. The total sale represents 7.3% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019.

Reuters last month

PFE

HLN
Teva Pharmaceutical Stock Scores RS Rating Upgrade

Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investor's Business Daily last month

COLL

ANIP

HLN
Pfizer to sell entire Haleon stake

Pfizer will sell about 662 million ordinary shares, or 7.3%, of Haleon, created in a merger of GSK and Pfizer's consumer healthcare businesses in 2019, and spun off in 2022. Under the deal, the Sensodyne maker has agreed to buy back shares worth $220 million from Pfizer, currently its largest shareholder.

Reuters last month

PFE

HLN
As trade war intensifies, Reckitt may be more exposed than some rivals

Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low manufacturing capacity there compared to some rivals leaves the company more exposed to new U.S. tariffs on imports from Mexico. Reckitt, which makes Lysol cleaning products and Durex condoms, has five factories in the United States. It told Reuters in early March that it manufactures about 57% of its U.S. sales volumes locally, with the other 43% coming from places including Mexico and Southeast Asia.

Reuters last month

RBGLY

HLN
Jim Cramer on Haleon plc (HLN): ‘Stock Has Been Up’

We recently published an article titled Jim Cramer Discusses These 11 Stocks & President Trump’s Tariffs. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other stocks Jim Cramer discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on President Trump’s latest […]

Insider Monkey last month

HLN
Why Haleon plc (HLN) Surged On Monday?

We recently published a list of 10 Stocks Lead Monday’s Charge Amid Market Bloodbath. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading week in a bloodbath, erasing last week’s gains, […]

Insider Monkey last month

HLN
Haleon PLC (HLN) (Q4 2024) Earnings Call Highlights: Strong Growth in Emerging Markets Amid ...

Haleon PLC (HLN) reports robust performance in India and China, while navigating FX headwinds and inventory management issues.

GuruFocus.com last month

HLN
Haleon Full Year 2024 Earnings: EPS Misses Expectations

Haleon ( LON:HLN ) Full Year 2024 Results Key Financial Results Revenue: UK£11.2b (flat on FY 2023). Net income...

Simply Wall St. last month

HLN

HLNCF
Is Haleon plc (HLN) the Best Low Price Pharma Stock to Invest In Right Now?

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments Healthcare, which includes numerous businesses that offer patient […]

Insider Monkey last month

HLN
Haleon beats Q4 organic growth estimates, but shares fall on 2025 guide

Investing.com -- HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Investing.com last month

HLN
Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK last month

E

EIPAF

SJM
Are Investors Undervaluing Haleon plc (LON:HLN) By 25%?

Key Insights The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity Current share...

Simply Wall St. last month

HLN

HLNCF
Haleon to invest $54 million in US R&D centre to boost product innovation

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations. The company said the investment is in addition to its 300 million pound ($372.5 million) annual spending in R&D. The Richmond facility is one of the three R&D centres of excellence for Haleon, along with Weybridge, UK and Suzhou, China. ($1 = 0.8053 pounds)

Reuters 2 months ago

HLN

Performance Overview

Return	HLN.L	FTSE 100 (^FTSE)
YTD	+2.38%	+1.90%
1-Year	+16.78%	+3.80%
3-Year	+17.09%	+10.73%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Haleon plc (HLN.L)

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

Sensodyne-maker axes diversity targets from bonuses

Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

Pfizer sells 7.3% stake in Haleon for $3.3bn

Top Midday Stories: EC Notifies Alphabet of DMA Noncompliance, Adopts Requirements for Apple; Boeing Expects Less Q1 Cash Outflow

Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant

Pfizer offloads final shares in Sensodyne maker Haleon

Pfizer sells entire Haleon stake for $3.24 billion

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Pfizer to sell entire Haleon stake

As trade war intensifies, Reckitt may be more exposed than some rivals

Jim Cramer on Haleon plc (HLN): ‘Stock Has Been Up’

Why Haleon plc (HLN) Surged On Monday?

Haleon PLC (HLN) (Q4 2024) Earnings Call Highlights: Strong Growth in Emerging Markets Amid ...

Haleon Full Year 2024 Earnings: EPS Misses Expectations

Is Haleon plc (HLN) the Best Low Price Pharma Stock to Invest In Right Now?

Haleon beats Q4 organic growth estimates, but shares fall on 2025 guide

Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin

Are Investors Undervaluing Haleon plc (LON:HLN) By 25%?

Haleon to invest $54 million in US R&D centre to boost product innovation

Performance Overview